Market Cap (In CNY)
6.47 Billion
Revenue (In CNY)
2.91 Billion
Net Income (In CNY)
297.41 Million
Avg. Volume
8.08 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.1-10.6
- PE
- 28.79
- EPS
- 0.29
- Beta Value
- 0.517
- ISIN
- CNE000001394
- CUSIP
- -
- CIK
- -
- Shares
- 846532000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Xu Xiang Ping
- Employee Count
- -
- Website
- https://www.hnjzt.com
- Ipo Date
- 2000-06-28
- Details
- Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria for cardiovascular and cerebrovascular disease; Guizhi Fuling pills, Buxue Shengru granules, and hemostasis and analgesia products for gynecological disease; Schicon for respiratory disease; and Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products for digestive disease. It also provides non-prescription drugs for treating nourishing QI and blood, cardiovascular and cerebrovascular, urinary system, pediatric, gynecological, skeletal muscle, respiratory, dermatology, nervous system, ENT, digestive system, and tumor diseases. Jiuzhitang Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.
More Stocks
-
MFGCFMayfair Gold Corp.
MFGCF
-
TTKTAKKT AG
TTK
-
KREKreditbanken A/S
KRE
-
000012CSG Holding Co., Ltd.
000012
-
002670
-
TETTreatt plc
TET
-
002032Zhejiang Supor Co., Ltd.
002032
-
IBS